Long-Term Outcome of the First Completely Leadless Cardiac Resynchronization Therapy in the United States.

ABSTRACT: Completely leadless cardiac resynchronization therapy is feasible with the combination of Micra AV pacemaker (Medtronic Inc) and WiSE-CRT (EBR Inc) systems. Several reports have highlighted this combination in Europe. This case report presents a 1- year follow-up the first reported concomitant use of the leadless systems in the United States. (Level of Difficulty: Advanced.).

SUBMITTER: Mehlhorn D 

PROVIDER: S-EPMC10589444 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature